Two Articles ...
Today, I had two articles appear in The Motley Fool. The first was on 3M and the second was on Harris and Harris.
I also encourage you to check out the news coming out of Biophan. It's recent agreement with Boston Scientific is good news. I have been down on the company in the past because I have felt it has relied on dubious press releases (of little substance) at the expense of real news. The deal with Boston qualifies as real news. I hope to be writing a little more on Biophan soon.
Jack Uldrich
I also encourage you to check out the news coming out of Biophan. It's recent agreement with Boston Scientific is good news. I have been down on the company in the past because I have felt it has relied on dubious press releases (of little substance) at the expense of real news. The deal with Boston qualifies as real news. I hope to be writing a little more on Biophan soon.
Jack Uldrich